Literature DB >> 35235157

The functional significance and cross-talk of non-coding RNAs in triple negative and quadruple negative breast cancer.

Utpalendu Paul1, Satarupa Banerjee2.   

Abstract

One of the leading causes of cancer-related deaths worldwide is breast cancer, among which triple-negative breast cancer (TNBC) is the most malignant and lethal subtype. This cancer accounts for 10-20% of all breast cancer deaths. Proliferation, tumorigenesis, and prognosis of TNBC are affected when the androgen receptor (AR) is not expressed, and it is classified as quadruple negative breast cancer (QNBC). Non-coding RNAs, such as microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), play a significant role in tumorigenesis by virtue of their oncogenic and tumor-suppressive properties. To regulate tumorigenesis, miRNAs interact with their target mRNAs and modulate their expression, whereas lncRNAs can either act alone or interact with miRNAs or other molecules through various signaling pathways. Conversely, circRNAs regulate tumorigenesis by acting as miRNA sponges predominantly. Recently, non-coding RNAs were studied comprehensively for their roles in tumor proliferation, progression, and metastasis. As a result of existing studies and research progress, non-coding RNAs have been implicated in TNBC, necessitating their use as biomarkers for future diagnostic applications. In this review, the non-coding RNAs are explicitly implicated in the regulation of breast cancer, and their cross-talk between TNBC and QNBC is also discussed.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Non-coding RNA; Quadruple negative breast cancer (QNBC); Triple negative breast cancer (TNBC); circRNA; lncRNA; miRNA

Mesh:

Substances:

Year:  2022        PMID: 35235157     DOI: 10.1007/s11033-022-07288-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  174 in total

Review 1.  Androgens and breast cancer.

Authors:  Joanne Kotsopoulos; Steven A Narod
Journal:  Steroids       Date:  2011-10-10       Impact factor: 2.668

2.  Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer.

Authors:  Maxwell N Skor; Erin L Wonder; Masha Kocherginsky; Anju Goyal; Ben A Hall; Yi Cai; Suzanne D Conzen
Journal:  Clin Cancer Res       Date:  2013-09-09       Impact factor: 12.531

Review 3.  Long Noncoding RNA: Genome Organization and Mechanism of Action.

Authors:  Vijay Suresh Akhade; Debosree Pal; Chandrasekhar Kanduri
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

4.  Extensive post-transcriptional regulation of microRNAs and its implications for cancer.

Authors:  J Michael Thomson; Martin Newman; Joel S Parker; Elizabeth M Morin-Kensicki; Tricia Wright; Scott M Hammond
Journal:  Genes Dev       Date:  2006-08-01       Impact factor: 11.361

Review 5.  MicroRNAs in triple-negative breast cancer.

Authors:  M Koleckova; M Janikova; Z Kolar
Journal:  Neoplasma       Date:  2018       Impact factor: 2.575

6.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

Review 7.  Androgen Receptor Biology in Triple Negative Breast Cancer: a Case for Classification as AR+ or Quadruple Negative Disease.

Authors:  Valerie N Barton; Nicholas C D'Amato; Michael A Gordon; Jessica L Christenson; Anthony Elias; Jennifer K Richer
Journal:  Horm Cancer       Date:  2015-07-23       Impact factor: 3.869

8.  Androgen receptor (AR) expression in 400 breast carcinomas: is routine AR assessment justified?

Authors:  Damoun Safarpour; Shabnam Pakneshan; Fattaneh A Tavassoli
Journal:  Am J Cancer Res       Date:  2014-07-16       Impact factor: 6.166

9.  Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features.

Authors:  Kristine Astvatsaturyan; Yong Yue; Ann E Walts; Shikha Bose
Journal:  PLoS One       Date:  2018-06-08       Impact factor: 3.240

Review 10.  The significance of exosomes in the development and treatment of hepatocellular carcinoma.

Authors:  Xin Li; Chuanyun Li; Liping Zhang; Min Wu; Ke Cao; Feifei Jiang; Dexi Chen; Ning Li; Weihua Li
Journal:  Mol Cancer       Date:  2020-01-04       Impact factor: 27.401

View more
  1 in total

Review 1.  Potential utility of miRNAs for liquid biopsy in breast cancer.

Authors:  Xiangrong Liu; Dimitri Papukashvili; Zhixiang Wang; Yan Liu; Xiaoxia Chen; Jianrong Li; Zhiyuan Li; Linjie Hu; Zheng Li; Nino Rcheulishvili; Xiaoqing Lu; Jinfeng Ma
Journal:  Front Oncol       Date:  2022-08-04       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.